VORVor Biopharma Inc.
23.36USD-0.93%Mkt Cap: 1.27B $P/E: 0.133d ago
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treat…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap1.27B $
Enterprise Value901.33M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-695.98M $
Revenue/Share—
Last Price23.36 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees76
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.13
P/E (Forward)-6.37
PEG—
EV/EBITDA-7.68
EV/Revenue—
P/S—
P/B-8.31
EPS (TTM)176.64
EPS (Forward)-3.62
52W Range
6.50039% of range50.20
52W High50.20 USD
52W Low6.500 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE423.57%
ROA-149.96%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-142.71M $
CapEx (TTM)941.00K $
FCF Margin—
FCF Yield-6.28%
Net Debt-463.25M $
Net Debt/EBITDA3.95
Balance Sheet
Debt/Equity-0.02
Current Ratio19.15
Quick Ratio18.79
Book Value/Sh-2.7760 USD
Cash/Share7.879 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateSep 19, 2025
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)39.00 USD
Upside (mean)+67.0%
Target Range27.00 USD – 50.00 USD
$27.00+67.0% to mean$50.00
# Analysts8
Ownership
Shares Out.54.19M
Float37.23M
Insiders3.91%
Institutions85.92%
Short Interest
Short Ratio5.8d
Short % Float16.01%
Short % Out.13.38%
Shares Short7.25M
Short (prev mo.)7.74M
Technical
SMA 5019.18 (+21.8%)
SMA 20015.19 (+53.7%)
Beta1.72
S&P 52W Chg18.16%
Avg Vol (30d)889.41K
Avg Vol (10d)788.30K
Technical Indicators
RSI (14)63.2
MACD1.3173
MACD Signal1.3840
MACD Hist.-0.0667
BB Upper25.28 USD
BB Middle21.95 USD
BB Lower18.62 USD
BB Width30.34%
ATR (14)1.346 USD
Vol Ratio (20d)0.78x